STUDY | PLUME CONCERNS IN SKIN RESURFACING TREATMENTS DURING COVID‐19 | Dr Spero J. Theodorou скачать в хорошем качестве

STUDY | PLUME CONCERNS IN SKIN RESURFACING TREATMENTS DURING COVID‐19 | Dr Spero J. Theodorou

A study titled “Plume Effect of Fractional Radiofrequency Versus Laser Resurfacing: Considerations in the COVID‐19 Pandemic” by bodySCULPT plastic surgeon Spero J. Theodorou, MD et al, was published in Lasers in Surgery and Medicine on November 8, 2020. The study recommends that plastic surgeons should use devices that generate little to no plume, such as radiofrequency devices, to minimize the risk of laser plume‐associated pathogen transmission during the reopening of practices in Phase 1. The study also suggests that it is best to avoid treatment with Er:YAG laser resurfacing devices, and if used, these should only be “used with appropriate personal protective equipment in addition to a smoke evacuator in Phase IV reopening.” The plume effect got noticed during the COVID‐19 pandemic as plastic surgeons enhanced their safety protocols during this time. They re‐evaluated their aesthetic practices to ensure optimal patient safety, especially when performing elective procedures using energy‐based devices and lasers. Previous studies have shown that the plume emitted by these devices contain tissue debris and aerosolized biological materials that could transmit viruses and bacteria. Through this study, the researchers were able to provide guidance to practitioners on the potential for viral transmission by comparing the plume generated by RF-based microneedling and Er:YAG fractional skin resurfacing. According to the study, “the U.S. Occupational Safety and Health Administration (OSHA) currently has no regulatory requirements for protection against plume emission from energy‐based devices and lasers devices. However, several professional societies, including the American Society for Lasers in Medicine and Surgery (ASLMS) have recommended guidelines to protect patients and practitioners”. To know more about this study, read our blog: https://www.bodysculpt.com/blog/study... Read the full article published in Lasers in Surgery and Medicine: https://www.bodysculpt.com/wp-content... Study author Dr Spero J. Theodorou is bodySCULPT® plastic surgeon and InMode’s Chief Medical Officer. Dr Theodorou has extensive training in radiofrequency-assisted and other power-assisted liposuction procedures. He is responsible for the development of all of InMode’s procedures, clinical studies and training. Dr Theodorou was instrumental in the development and introduction of EmbraceRF, the innovative facial contouring solution that blends InMode’s FaceTite and Morpheus8.